Related references
Note: Only part of the references are listed.Cancer multidrug resistance: mechanisms involved and strategies for circumvention using a drug delivery system
Golam Kibria et al.
ARCHIVES OF PHARMACAL RESEARCH (2014)
The effect of liposomal size on the targeted delivery of doxorubicin to Integrin αvβ3-expressing tumor endothelial cells
Golam Kibria et al.
BIOMATERIALS (2013)
Increased Expression of P-Glycoprotein and Doxorubicin Chemoresistance of Metastatic Breast Cancer Is Regulated by miR-298
Lili Bao et al.
AMERICAN JOURNAL OF PATHOLOGY (2012)
Impact of mutant β-catenin on ABCB1 expression and therapy response in colon cancer cells
U. Stein et al.
BRITISH JOURNAL OF CANCER (2012)
Inhibition of STAT1 sensitizes renal cell carcinoma cells to radiotherapy and chemotherapy
Hongxia Zhu et al.
CANCER BIOLOGY & THERAPY (2012)
Role of hypoxia and glycolysis in the development of multi-drug resistance in human tumor cells and the establishment of an orthotopic multi-drug resistant tumor model in nude mice using hypoxic pre-conditioning
Lara Milane et al.
CANCER CELL INTERNATIONAL (2011)
Phenotyping breast cancer cell lines EM-G3, HCC1937, MCF7 and MDA-MB-231 using 2-D electrophoresis and affinity chromatography for glutathione-binding proteins
Jana Mladkova et al.
BMC CANCER (2010)
Suppression of Hypoxia-inducible Factor 2α Restores p53 Activity via Hdm2 and Reverses Chemoresistance of Renal Carcinoma Cells
Andrew M. Roberts et al.
CANCER RESEARCH (2009)
ABCG2: the key to chemoresistance in cancer stem cells?
Yi An et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2009)
P-glycoprotein activity in renal clear cell carcinoma
Elena Soto-Vega et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2009)
Reversal of drug resistance in ovarian cancer: Where do we go from here?
Stan B. Kaye
JOURNAL OF CLINICAL ONCOLOGY (2008)
Structure, function and regulation of P-glycoprotein and its clinical relevance in drug disposition
S. -F. Zhou
XENOBIOTICA (2008)
Clinical pharmacology of liposomal anthracyclines: Focus on pegylated liposomal doxorubicin
Rebecca Solomon et al.
CLINICAL LYMPHOMA & MYELOMA (2008)
Inhibition of the mitogen-activated protein kinase pathway results in the down-regulation of P-glycoprotein
Kazuhiro Katayama et al.
MOLECULAR CANCER THERAPEUTICS (2007)
The roles of four multi-drug resistance proteins in hepatocellular carcinoma multidrug resistance
Li Gaopeng et al.
JOURNAL OF HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY-MEDICAL SCIENCES (2007)
Recent advances in cancer stem/progenitor cell research: therapeutic implications for overcoming resistance to the most aggressive cancers
M. Mimeault et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2007)
Estrogen-mediated post transcriptional down-regulation of P-glycoprotein in MDR1-transduced human breast cancer cells
Kazuyoshi Mutoh et al.
CANCER SCIENCE (2006)
Human multidrug resistance ABCB and ABCG transporters:: Participation in a chemoimmunity defense system
Balazs Sarkadi et al.
PHYSIOLOGICAL REVIEWS (2006)
Biomarkers and multiple drug resistance in breast cancer
L. O'Driscoll et al.
CURRENT CANCER DRUG TARGETS (2006)
Therapeutic approaches in metastatic renal cell carcinoma
M Staehler et al.
BJU INTERNATIONAL (2005)
The selective retinoid X receptor agonist bexarotene (LGD1069, Targretin) prevents and overcomes multidrug resistance in advanced breast carcinoma
WC Yen et al.
MOLECULAR CANCER THERAPEUTICS (2005)
Inhibition of bcl-2 enhances the efficacy of chemotherapy in renal cell carcinoma
I Kausch et al.
EUROPEAN UROLOGY (2005)
Major vault protein does not play a role in chemoresistance or drug localization in a non-small cell lung cancer cell line
KE Huffman et al.
BIOCHEMISTRY (2005)
ABC transporters as multidrug resistance mechanisms and the development of chemosensitizers for their reversal
Cheol-Hee Choi
CANCER CELL INTERNATIONAL (2005)
Role of multiple drug resistance protein 1 in neutral but not acidic glycosphingolipid biosynthesis
MF De Rosa et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Relationship between antiapoptotic molecules and metastatic potency and the involvement of DNA-dependent protein kinase in the chemosensitization of metastatic human cancer cells by epidermal growth factor receptor blockade
JH Um et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2004)
Anthracyclines: Molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity
G Minotti et al.
PHARMACOLOGICAL REVIEWS (2004)
Nicotine induces multi-site phosphorylation of bad in association with suppression of apoptosis
ZH Jin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Effect of flavonoids on MRP1-mediated transport in Panc-1 cells
H Nguyen et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2003)
Mammalian drug efflux transporters of the ATP binding cassette (ABC) family: an overview
AH Schinkel et al.
ADVANCED DRUG DELIVERY REVIEWS (2003)
Tumor regression by combination antisense therapy against Plk1 and Bcl-2
R Elez et al.
ONCOGENE (2003)
Methylation-dependent silencing of the reduced folate carrier gene in inherently methotrexate-resistant human breast cancer cells
J Worm et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Chemosensitization of human renal cell cancer using antisense oligonucleotides targeting the antiapoptotic gene clusterin
T Zellweger et al.
NEOPLASIA (2001)
Activity of a novel bcl-2/bcl-xL-bispecific antisense oligonucleotide against tumors of diverse histologic origins
O Gautschi et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2001)
Drug resistance in cancer: A perspective
JH Goldie
CANCER AND METASTASIS REVIEWS (2001)
Multicellular resistance: a paradigm for clinical resistance?
B Desoize et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2000)
Share Paper
